Each structure will be positioned six meters above the road surface and must feature non-slip flooring to ensure safety ...
Company scheduled to meet with the FDA in mid-April 2026 to review the results of the Phase 3 EFZO-FIT study and determine the path forward for efzofitimod in pulmonary sarcoidosis. Phase 2 EFZO-CONNE ...
A recent investigation in Bengaluru has raised fresh concerns about food safety. Tests found dangerous levels of lead in ...
During a live event, Joshua Richter, MD, explored proactive adverse event management when using selinexor in multiple myeloma. At a live Case-Based Roundtable event during the 2025 American Society of ...
Company scheduled to meet with the FDA in mid-April 2026 to review the results of the Phase 3 EFZO-FIT™ study and determine ...
Accelerated review was enabled by the Commissioner’s National Priority Voucher Pilot Program, targeting high unmet need and compressing FDA action to 1–2 months with enhanced reviewer communication.
In the Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with biliary tract cancer, the prespecified ...